# Contact — peptidesinburleson

> Research correspondence and editorial inquiries for peptidesinburleson — an independent literature digest on the Wolverine blend, BPC-157, and TB-500.

For editorial questions, citation corrections, or research-literature inquiries.

## Reach the desk

This desk welcomes correspondence on editorial matters: citation corrections, newly published research that may be relevant to an existing compound page, or factual clarifications. All of the content here rests on specific sources — if a reference is broken, misattributed, or has been superseded by a more current study, that is genuinely useful to hear.

Email: **editorial@peptidesinburleson.com**

Note that this is an editorial address for a research digest, not a clinical service. We cannot answer questions about individual medical situations, recommend protocols, evaluate test results, or provide any form of medical guidance. Correspondence of that kind is better directed to a licensed clinician.

## What we do not handle

To set clear expectations:

- **No medical or dosing advice.** We do not advise on whether any research peptide is appropriate for any specific person, condition, or protocol. This is a literature desk.
- **No vendor referrals.** We do not recommend, link to, or evaluate suppliers of research peptides or any other substance.
- **No clinical consultations.** If you have a medical concern, please contact a licensed healthcare provider.

For citation issues, missing or incorrect references, or questions about the editorial scope of a compound page, the editorial address above is the right channel.

---

An independent literature digest: citations, mechanisms, and honest evidence limits — never doses, never products.